Crawford set to change FDA's "unwieldy" device panels
This article was originally published in Clinica
Executive Summary
The FDA intends to reorganise its once-vaunted advisory committee system, believing that some panels now have so many members that they have become unwieldy, acting commissioner Lester Crawford said last week.